Literature DB >> 3346946

Molecular analysis of viral RNAs in mice persistently infected with lymphocytic choriomeningitis virus.

S J Francis1, P J Southern.   

Abstract

Infection of newborn mice with lymphocytic choriomeningitis virus (LCMV) results in a lifelong persistent infection. Persistently infected animals continuously produce low levels of infectious virus and accumulate large amounts of intracellular viral nucleic acid (P. J. Southern, P. Blount, and M. B. A. Oldstone, Nature [London] 312:555-558, 1984). We have used gel electrophoresis and hybridization techniques to analyze viral RNAs that appear during the establishment and maintenance of a persistent LCMV infection in vivo to identify any role for defective and/or defective interfering RNAs. We have found a complex, heterogeneously sized population of viral RNAs in multiple independent tissues that is uniquely associated with persistent infections in vivo, but we have not yet established whether these RNAs have a causal or a consequential association with persistent infection by LCMV. Within the complex virus RNA population, full-length genomic L and S RNAs were readily detectable and represented the most abundant individual viral RNA species. RNAs apparently corresponding in size to the viral nucleoprotein and glycoprotein mRNAs could also be detected in these tissue RNA samples. The presence of glycoprotein mRNA indicates a potential mechanism of posttranscriptional regulation to account for the previously documented restriction in viral glycoprotein expression in persistently infected mice (M. B. A. Oldstone and M. J. Buchmeier, Nature (London) 300:360-362, 1982).

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3346946      PMCID: PMC253134     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  35 in total

1.  Isolation and characterization of Sendai virus DI-RNAs.

Authors:  D Kolakofsky
Journal:  Cell       Date:  1976-08       Impact factor: 41.582

2.  Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I.

Authors:  P W Rigby; M Dieckmann; C Rhodes; P Berg
Journal:  J Mol Biol       Date:  1977-06-15       Impact factor: 5.469

Review 3.  Defective interfering viruses.

Authors:  A S Huang
Journal:  Annu Rev Microbiol       Date:  1973       Impact factor: 15.500

4.  Properties of defective lymphocytic choriomeningitis virus.

Authors:  R M Welsh; C M O'Connell; C J Pfau
Journal:  J Gen Virol       Date:  1972-12       Impact factor: 3.891

5.  Analysis of the genomic L RNA segment from lymphocytic choriomeningitis virus.

Authors:  M K Singh; F V Fuller-Pace; M J Buchmeier; P J Southern
Journal:  Virology       Date:  1987-12       Impact factor: 3.616

6.  Defective interfering particles in mice infected with lymphocytic choriomeningitis virus.

Authors:  M Popescu; F Lehmann-Grube
Journal:  Virology       Date:  1977-03       Impact factor: 3.616

7.  Determinants of lymphocytic choriomeningitis interference.

Authors:  R M Welsh; C J Pfau
Journal:  J Gen Virol       Date:  1972-02       Impact factor: 3.891

8.  The RNAs of the defective interfering Pichinide virus.

Authors:  F J Dutko; E A Wright; C J Pfau
Journal:  J Gen Virol       Date:  1976-06       Impact factor: 3.891

9.  Inhibition of immunologic injury of cultured cells infected with lymphocytic choriomeningitis virus: role of defective interfering virus in regulating viral antigenic expression.

Authors:  R M Welsh; M B Oldstone
Journal:  J Exp Med       Date:  1977-06-01       Impact factor: 14.307

10.  Immunopathogenesis of acute central nervous system disease produced by lymphocytic choriomeningitis virus. II. Adoptive immunization of virus carriers.

Authors:  D H Gilden; G A Cole; N Nathanson
Journal:  J Exp Med       Date:  1972-04-01       Impact factor: 14.307

View more
  8 in total

1.  NP and L proteins of lymphocytic choriomeningitis virus (LCMV) are sufficient for efficient transcription and replication of LCMV genomic RNA analogs.

Authors:  K J Lee; I S Novella; M N Teng; M B Oldstone; J C de La Torre
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

2.  Concurrent sequence analysis of 5' and 3' RNA termini by intramolecular circularization reveals 5' nontemplated bases and 3' terminal heterogeneity for lymphocytic choriomeningitis virus mRNAs.

Authors:  B J Meyer; P J Southern
Journal:  J Virol       Date:  1993-05       Impact factor: 5.103

3.  Detection of virus-specific RNA-dependent RNA polymerase activity in extracts from cells infected with lymphocytic choriomeningitis virus: in vitro synthesis of full-length viral RNA species.

Authors:  F V Fuller-Pace; P J Southern
Journal:  J Virol       Date:  1989-05       Impact factor: 5.103

4.  Homologous interference of lymphocytic choriomeningitis virus involves a ribavirin-susceptible block in virus replication.

Authors:  A Géssner; H Lother
Journal:  J Virol       Date:  1989-04       Impact factor: 5.103

5.  Role of an intact splenic microarchitecture in early lymphocytic choriomeningitis virus production.

Authors:  Stefan Müller; Lukas Hunziker; Susanne Enzler; Myriam Bühler-Jungo; James P Di Santo; Rolf M Zinkernagel; Christoph Mueller
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

6.  Visualization of Arenavirus RNA Species in Individual Cells by Single-Molecule Fluorescence In Situ Hybridization Suggests a Model of Cyclical Infection and Clearance during Persistence.

Authors:  Benjamin R King; Aubin Samacoits; Philip L Eisenhauer; Christopher M Ziegler; Emily A Bruce; Daniel Zenklusen; Christophe Zimmer; Florian Mueller; Jason Botten
Journal:  J Virol       Date:  2018-05-29       Impact factor: 5.103

7.  Strand-Specific Quantitative Reverse Transcription-Polymerase Chain Reaction Assay for Measurement of Arenavirus Genomic and Antigenomic RNAs.

Authors:  Kelsey Haist; Christopher Ziegler; Jason Botten
Journal:  PLoS One       Date:  2015-05-15       Impact factor: 3.240

Review 8.  Virus infection of polarized epithelial cells.

Authors:  S P Tucker; R W Compans
Journal:  Adv Virus Res       Date:  1993       Impact factor: 9.937

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.